As there is variation among ependymal-like cases for proliferation rate and presence of necrosis, without clear associations for clinical outcome within a potentially molecularly defined entity, general characterization of PLAGL1 rearranged neuroepithelial tumors as low-grade or high grade may yet be premature. The gene discussed is PLAGL1; the disease is neuroepithelial neoplasm.